NFKB1 and inflammatory bowel disease: It has been shown that PPAR-α activation increases the expression of IкB-α and prevents the translocation of p50/p65 in the cell nucleus, and the absence of PPAR-α gene resulted in the augmentation of IBD pathologies (16).